Trade Mark Journal No.2026/046 13 November 2026
WO0000001944911 (40,42)
Office of origin: Switzerland
Date of International Registration:6 July 2026
Date of designation in the UK:
6 July 2026
International priority date claimed: 16 June 2026
(Switzerland)
(851529)
- Class 40
- Custom manufacturing, to order and according to the specifications of third parties of biopharmaceuticals, namely the manufacture of pharmaceutical active ingredients, biologics, recombinant proteins, monoclonal antibodies, and other biopharmaceutical products for the pharmaceutical and life sciences industries; Custom manufacturing of biopharmaceuticals to order and according to the specifications of third parties using bioprocesses and fed-batch cell culture processes.
- Class 42
- Technological and scientific services related to the development, design, optimization and transfer of biopharmaceutical manufacturing processes; Research and development services in the field of biotechnology and pharmaceutical manufacturing; process development, process characterization, process scaling, and optimization of manufacturing processes for pharmaceutical active ingredients, biologics and other biopharmaceutical products; Technical consulting for drug manufacturing optimization and fed-batch manufacturing services.
Lonza Ltd.
Representative: von Arx Schmidiger Faber Rechtsanwälte, Neumarkt 15, CH-8405 Winterthur, SWITZERLAND